Economic Assessment of the Secondary Prevention of Ischaemic Events with Lysine Acetylsalicylate

Author： Marissal J-P.   Selke B.   Lebrun T.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.18, Iss.2, 2000-08, pp. : 185-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin cost effective for secondary prevention of ischaemic events

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 282, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Economic Assessment of the Secondary Prevention of Ischaemic Stroke with Dipyridamole plus Aspirin (Aggrenox ® /Asasantin ® ) in France

By Jean-Pierre Marissal   Bernard Selke  

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 661-670

Adis International

Access to resources Recommend Favorite

Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events: An Assessment from the Payer's Perspective

By Heeg Bart  

PharmacoEconomics, Vol. 25, Iss. 12, 2007-01 ,pp. : 1063-1082

Adis International

Access to resources Recommend Favorite

Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke

By Ringleb Peter A   Schwark Christian   Schwaninger Markus   Schellinger Peter D  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. : 359-367

Informa Healthcare

Access to resources Recommend Favorite

Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events

By Ling Geoffrey  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 3, 2009-05 ,pp. : 197-209

Adis International

Access to resources Recommend Favorite